HARBIN, China, July 21, 2010 (GLOBE NEWSWIRE) -- Tongli Pharmaceuticals (USA) Inc. (OTCBB:TGLP), announced the following three of its products have been included in China’s Essential Drug List (“EDL”): Calcium Gluconate Oral Liquid, Metformin Hydrochloride Tablets, Clindamycin Hydrochloride. As a result of their EDL status, a greater part of the cost for these products will be covered by China’s government sponsored programs, therefore the Company expects it a positive factor in boosting the sales volumes.
